---
title: "G Medical Innovations Holdings Ltd (GMVDF.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/GMVDF.US.md"
symbol: "GMVDF.US"
name: "G Medical Innovations Holdings Ltd"
industry: "Health Care Services"
---

# G Medical Innovations Holdings Ltd (GMVDF.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Location | US Market |
| Website | [gmedinnovations.com](https://gmedinnovations.com) |

## Company Profile

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company’s products include Prizma, a plug-and-play med...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-22T04:30:12.000Z

**Overall: D (0.64)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 79 / 86 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -10.91% |  |
| Net Profit YoY | 6.47% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 26441.70 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 4.42M |  |


**Multi Score**: D

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 202.05% | A |
| Profit Margin | -305.90% | E |
| Gross Margin | 17.74% | D |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -10.91% | D |
| Net Profit YoY | 6.47% | C |
| Total Assets YoY | -54.12% | E |
| Net Assets YoY | -62.55% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -32.69% | D |
| OCF YoY | -10.91% | D |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.58 | B |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 194.74% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - G Medical Innovations Holdings Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "202.05%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-305.90%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "17.74%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-10.91%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "6.47%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-54.12%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-62.55%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-32.69%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-10.91%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.58",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "194.74%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | TalkSpace (US.TALK) | C | B | A | A | A | A |
| 02 | Cigna (US.CI) | B | B | A | D | B | B |
| 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B |
| 04 | Labcorp (US.LH) | B | C | B | C | B | B |
| 05 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2024-01-17T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.00 |
| Highest Target | 210.00 |
| Lowest Target | 210.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/GMVDF.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/GMVDF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/GMVDF.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.